Power Law company profile

Kuros Biosciences

Biotech & Life Sciences · Zurich, Switzerland · Founded 2000 · IPO 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$739M

Market cap · Apr/2026

Revenue

$134M

Latest reported FY

Investors

14 investors on Kuros Biosciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Series B+ 10 investors entered at this stage

Patent intelligence

$38M patent portfolio · 15 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$38M

5.2% of market cap · 184.7× smaller than top peer Janssen Vaccines ($7.1B)

15 active patent families

Where Kuros Biosciences innovates Biomedical engineeringVirus-like particleTGE VACCINEMolecular biologyAntibody response

Above peer median on Market · Below peer median on Legal, Strategic

Quality vs same-sector peers

Kuros Biosciences on the five Patsnap quality dimensions

Kuros Biosciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Kuros Biosciences concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Kuros Biosciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Kuros Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo